Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple Myeloma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2013-05-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-12-0782PMID 23729400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Program in Gene Function and Expression Publications and Presentations Program in Gene Function and Expression 1-1-2010 Transcriptional regulation of VEGF-A by the unfolded protein response pathway

  2014cited by this paper
• Stress-induced self-cannibalism: on the regulation of autophagy by endoplasmic reticulum stress

  2013cited by this paper
• Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma

  2012cited by this paper
• Crosstalk between the UPR and autophagy pathway contributes to handling cellular stress in neurodegenerative disease

  2012cited by this paper
• Reovirus as a Viable Therapeutic Option for the Treatment of Multiple Myeloma

  2012cited by this paper
• The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule

  2012cited by this paper
• The unfolded protein response: controlling cell fate decisions under ER stress and beyond

  2012cited by this paper
• Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib

  2012cited by this paper
• Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1

  2012cited by this paper
• The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma

  2011cited by this paper
• A Conserved Structural Determinant Located at the Interdomain Region of Mammalian Inositol-requiring Enzyme 1α*

  2011cited by this paper
• Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease

  2011cited by this paper
• Targeting HSP 90 Induces Apoptosis and Inhibits Critical Survival and Proliferation Pathways in Multiple Myeloma

  2011cited by this paper
• Initial genome sequencing and analysis of multiple myeloma

  2011cited by this paper
• Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study

  2011cited by this paper
• Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101

  2011cited by this paper
• Targeting hypoxia in cancer therapy

  2011cited by this paper
• Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma.

  2011cited by this paper
• Anti-apoptotic function of Xbp1 as an IL-3 signaling molecule in hematopoietic cells

  2011cited by this paper
• Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response

  2011cited by this paper
• Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.

  2011cited by this paper
• IRE1α Disruption Causes Histological Abnormality of Exocrine Tissues, Increase of Blood Glucose Level, and Decrease of Serum Immunoglobulin Level

  2010cited by this paper
• Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myeloma

  2010cited by this paper
• Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth.

  2010cited by this paper
• HSP72 Protects Cells from ER Stress-induced Apoptosis via Enhancement of IRE1α-XBP1 Signaling through a Physical Interaction

  2010cited by this paper
• XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments.

  2010cited by this paper
• Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma

  2010cited by this paper
• Transcriptional Regulation of VEGF-A by the Unfolded Protein Response Pathway

  2010cited by this paper
• Mechanisms of ER Stress-Mediated Mitochondrial Membrane Permeabilization

  2010cited by this paper
• Bifunctional Apoptosis Regulator (BAR), an Endoplasmic Reticulum (ER)-associated E3 Ubiquitin Ligase, Modulates BI-1 Protein Stability and Function in ER Stress*

  2010influential reference
• Regulated Ire1-dependent decay of messenger RNAs in mammalian cells

  2009cited by this paper
• Targeting the endoplasmic reticulum-stress response as an anticancer strategy.

  2009cited by this paper
• ORIGINAL ARTICLE Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells

  2009cited by this paper
• ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells

  2009cited by this paper
• Aminopeptidase inhibition as a targeted treatment strategy in myeloma

  2009cited by this paper
• ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum.

  2008influential reference
• Targeting the UPS as therapy in multiple myeloma

  2008cited by this paper
• HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma

  2008cited by this paper
• Myc regulates aggresome formation, the induction of Noxa, and apoptosis in response to the combination of bortezomib and SAHA.

  2008cited by this paper
• A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

  2008cited by this paper
• Patterns of somatic mutation in human cancer genomes

  2007cited by this paper
• Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.

  2007cited by this paper
• Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells.

  2007cited by this paper
• Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.

  2007cited by this paper
• The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis

  2007cited by this paper
• Human X‐Box binding protein‐1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines

  2007cited by this paper
• XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks.

  2007cited by this paper
• Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.

  2006cited by this paper
• Mediators of endoplasmic reticulum stress‐induced apoptosis

  2006cited by this paper
• Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma

  2006cited by this paper
• Proapoptotic BAX and BAK Modulate the Unfolded Protein Response by a Direct Interaction with IRE1α

  2006cited by this paper
• Heat shock proteins in cancer: chaperones of tumorigenesis.

  2006cited by this paper
• The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling

  2006cited by this paper
• Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.

  2006cited by this paper
• Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells

  2006influential reference
• Proapoptotic BAX and BAK Modulate the Unfolded Protein Response by a Direct Interaction with IRE1a

  2006cited by this paper
• Antimyeloma activity of heat shock protein-90 inhibition.

  2005cited by this paper
• Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma.

  2005cited by this paper
• ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth

  2005cited by this paper
• Identification of genes modulated in multiple myeloma using genetically identical twin samples.

  2004cited by this paper
• XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.

  2004cited by this paper
• Transcriptional regulatory cascades controlling plasma cell differentiation

  2003cited by this paper
• Activation signal of nuclear factor-kappa B in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2.

  2003cited by this paper
• The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.

  2003cited by this paper
• Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

  2003cited by this paper
• Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival

  2003cited by this paper
• Heat Shock Protein 90 Modulates the Unfolded Protein Response by Stabilizing IRE1α

  2002cited by this paper
• The Luminal Domain of ATF6 Senses Endoplasmic Reticulum (ER) Stress and Causes Translocation of ATF6 from the ER to the Golgi*

  2002cited by this paper
• Molecular sequelae of proteasome inhibition in human multiple myeloma cells

  2002influential reference
• Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha.

  2002cited by this paper
• IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

  2002cited by this paper
• Gadd153 Sensitizes Cells to Endoplasmic Reticulum Stress by Down-Regulating Bcl2 and Perturbing the Cellular Redox State

  2001cited by this paper
• The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

  2001cited by this paper
• XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.

  2001cited by this paper
• Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1.

  2000cited by this paper
• A regulatory link between ER-associated protein degradation and the unfolded-protein response.

  2000cited by this paper
• Regulated translation initiation controls stress-induced gene expression in mammalian cells.

  2000cited by this paper
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

  1988cited by this paper

• Regulation of stress tolerance by CREB1 sustains multiple myeloma cell survival

  2026cites this paper
• Direct optical activation of human IRE1 identifies unique patterns of transcriptional and post-transcriptional mRNA regulation in the unfolded protein response

  2025cites this paper
• EP4 influences bortezomib resistance in multiple myeloma by modulating endoplasmic reticulum stress via the phosphatidylinositol 3-kinase/protein kinase B pathway.

  2025cites this paper
• The Unfolded Protein Response in Sarcomas: From Proteostasis to Therapy Resistance

  2025cites this paper
• Single-cell transcriptomics identifies PDIA4 as a marker of progression and therapeutic vulnerability in multiple myeloma

  2025cites this paper
• The proteostasis network is a therapeutic target in acute myeloid leukemia

  2025cites this paper
• Mechanism regulation of endoplasmic reticulum stress in multiple myeloma cells: modulation of the UPR, UPS, autophagy, HSPs, and potential therapeutic targets

  2025cites this paper
• Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy

  2025cites this paper
• In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma

  2025cites this paper
• Optogenetic Clustering of Human IRE1 Reveals Differential Regulation of Transcription and mRNA Splice Isoform Abundance by the UPR

  2025cites this paper
• The UPR-oxidative stress nexus in diabetes and obesity: Exploring innovative therapeutic approaches for metabolic control

  2025cites this paper
• Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway

  2025cites this paper
• Endoplasmic reticulum stress responses in anticancer immunity

  2025cites this paper
• Endoplasmic reticulum stress pathways and cellular death mechanisms in patients with phenylketonuria

  2025cites this paper
• High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target

  2025cites this paper
• Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myeloma

  2025cites this paper
• Knockdown of RRBP1 regulates endoplasmic reticulum stress to mitigate malignant progression and suppress bortezomib resistance of multiple myeloma cells by inhibiting GRP78 expression.

  2025cites this paper
• Discovery of 5-Hydroxy-1,4-naphthoquinone (Juglone) Derivatives as Dual Effective Agents Targeting Platelet-Cancer Interplay through Protein Disulfide Isomerase Inhibition

  2024cites this paper
• Endothelial Unfolded Protein Response‐Mediated Cytoskeletal Effects

  2024cites this paper
• Inhibition of FOXM1 synergizes with BCL2 inhibitor Venetoclax in killing non-t(11;14) multiple myeloma cells via repressing MYC pathway

  2024cites this paper
• An unbiased lncRNA dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for multiple myeloma

  2024cites this paper
• Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 17p Myeloma Models

  2024cites this paper
• Tumor microenvironment signaling and therapeutics in cancer progression

  2023cites this paper
• Analysis of signaling cascades from myeloma cells treated with pristimerin.

  2023cites this paper
• Negligible role of TRAIL death receptors in cell death upon endoplasmic reticulum stress in B-cell malignancies

  2023cites this paper
• Lactoferrin ameliorates carfilzomib-induced renal and pulmonary deficits: Insights to the inflammasome NLRP3/NF-κB and PI3K/Akt/GSK-3β/MAPK axes.

  2023cites this paper
• High-content microscopy reveals a morphological signature of bortezomib resistance

  2023cites this paper
• A Potential Target for Treating Acute Myeloid Leukemia: XBP1 involved in Endoplasmic Reticulum Stress

  2023cites this paper
• Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate

  2023influential citation
• Bioactive Phytoconstituents and Their Therapeutic Potentials in the Treatment of Haematological Cancers: A Review

  2023cites this paper
• Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma.

  2023cites this paper
• High-content microscopy reveals a morphological signature of bortezomib resistance

  2023cites this paper
• Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma

  2023cites this paper
• Autophagy and the Bone Marrow Microenvironment: A Review of Protective Factors in the Development and Maintenance of Multiple Myeloma

  2022cites this paper
• Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.

  2022cites this paper
• Wnt inhibitors reduce the unfolded protein response and enhance bortezomib-induced cell death in multiple myeloma

  2022cites this paper
• SMG1, a nonsense‐mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma

  2022cites this paper
• Perillyl alcohol and its synthetic derivatives: the rising of a novel class of selective and potent antitumoral compounds

  2022cites this paper
• The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma

  2022cites this paper
• Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche

  2022cites this paper
• Interplay between fat cells and immune cells in bone: Impact on malignant progression and therapeutic response.

  2022cites this paper
• Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma

  2022cites this paper
• Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNK

  2022cites this paper
• IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies

  2022cites this paper
• Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells

  2022cites this paper
• Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?

  2022cites this paper
• Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications

  2021cites this paper
• Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma

  2021cites this paper
• An interdomain helix in IRE1α mediates the conformational change required for the sensor's activation

  2021cites this paper
• Endoplasmic reticulum stress and proteasome inhibitors in multiple myeloma - a room for improvement.

  2021cites this paper
• Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction

  2021influential citation
• Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

  2021cites this paper
• Oxidatively modified low‐density lipoproteins are potential mediators of proteasome inhibitor resistance in multiple myeloma

  2021cites this paper
• Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition

  2021cites this paper
• Mechanisms Driving Resistance to Proteasome Inhibitors Bortezomib, Carfilzomib, and Ixazomib in Multiple Myeloma

  2021cites this paper
• The Sec61 translocon is a therapeutic vulnerability in multiple myeloma

  2021cites this paper
• Exploring the In Vivo and In Vitro Anticancer Activity of Rhenium Isonitrile Complexes.

  2020cites this paper
• Endoplasmic reticulum stress: an arising target for metal-based anticancer agents.

  2020cites this paper
• Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma

  2020cites this paper
• Resistance to the Proteasome Inhibitors: Lessons from Multiple Myeloma and Mantle Cell Lymphoma.

  2020cites this paper
• DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway

  2020cites this paper
• Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma

  2020cites this paper
• Multiple Myeloma: Available Therapies and Causes of Drug Resistance

  2020cites this paper
• The connector between the kinase and RNase domains of IRE1α transmits the conformational change that underlies ER stress-induced activation

  2020cites this paper
• Cooperative treatment effectiveness of ATR and HSP90 inhibition in Ewing’s sarcoma cells

  2020cites this paper
• Transgenerational metabolic disorders and reproduction defects induced by benzo[a]pyrene in Xenopus tropicalis.

  2020cites this paper
• Endoplasmic reticulum stress signals in the tumour and its microenvironment

  2020cites this paper
• Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78

  2020cites this paper
• Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies.

  2020cites this paper
• Multiple Myeloma-Derived Extracellular Vesicles Induce Osteoclastogenesis through the Activation of the XBP1/IRE1α Axis

  2020cites this paper
• Molecular characterization and expression pattern of inositol-requiring enzyme 1 (IRE1) in blunt snout bream (Megalobrama amblycephala): its role of IRE1 involved in inflammatory response induced by lipopolysaccharide

  2020cites this paper
• Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib

  2020cites this paper
• Emerging protein kinase inhibitors for the treatment of multiple myeloma

  2019cites this paper
• Regulation of tumor–stroma interactions by the unfolded protein response

  2019cites this paper
• Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma.

  2019cites this paper
• Celastrol induce apoptosis of human multiple myeloma cells involving inhibition of proteasome activity

  2019cites this paper
• Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial

  2019cites this paper
• Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma

  2019cites this paper
• Unfolded Protein Response (UPR) in Survival, Dormancy, Immunosuppression, Metastasis, and Treatments of Cancer Cells

  2019cites this paper
• Sphingolipids and the unfolded protein response.

  2019cites this paper
• The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway

  2019cites this paper
• Three-Dimensional Plasma Cell Survival Microniche in Multiple Myeloma

  2019cites this paper
• Proteomic Analysis of Porcine Pre-ovulatory Follicle Differentiation Into Corpus Luteum

  2019cites this paper
• Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway.

  2018cites this paper
• Nelfinavir Induces Endoplasmic Reticulum Stress and Sensitizes Renal Cancer Cells to TRAIL

  2018cites this paper
• The role of carfilzomib in treatment of newly diagnosed multiple myeloma.

  2018cites this paper
• Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells

  2018cites this paper
• Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies

  2018cites this paper
• Withaferin A and Withanolide D Analogues with Dual Heat-Shock-Inducing and Cytotoxic Activities: Semisynthesis and Biological Evaluation.

  2018cites this paper
• Practical Aspects of the Use of Carfilzomib in Multiple Myeloma

  2018cites this paper
• Resistance Mechanisms to Novel Therapies in Myeloma

  2018influential citation
• Disruption of IRE1α through its kinase domain attenuates multiple myeloma

  2018cites this paper
• HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome

  2018cites this paper
• High NRF2 expression controls endoplasmic reticulum stress induced apoptosis in multiple myeloma.

  2018cites this paper
• Regulated Cell Death of Lymphoma Cells after Graded Mitochondrial Damage is Differentially Affected by Drugs Targeting Cell Stress Responses

  2018cites this paper
• Resistance to proteasome inhibitors and other targeted therapies in myeloma

  2018influential citation
• Homeostatic interplay between FoxO proteins and ER proteostasis in cancer and other diseases.

  2018cites this paper
• The proapoptotic, HIV protease generated Casp8p41 when bound and inactivated 1 by Bcl2, is degraded by the proteasome

  2018cites this paper
• Induction of Pro-Apoptotic Endoplasmic Reticulum Stress in Multiple Myeloma Cells by NEO214, Perillyl Alcohol Conjugated to Rolipram

  2018cites this paper
• Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance

  2018cites this paper